华赛生物完成近亿元A轮融资，加速绿色合成产品商业、产能落地

Core Viewpoint - Suzhou Huasai Biotechnology Co., Ltd. has completed nearly 100 million RMB in Series A financing, focusing on innovative and green development in the field of synthetic biology [4][6]. Group 1: Company Overview - Huasai Biotechnology is led by Dr. Hu Zhihao, a recipient of the "Green Chemistry Challenge Award" in the U.S., and has developed a synthetic biology and metabolic engineering platform [4]. - The company aims to address high energy consumption and emissions in traditional chemical synthesis or fermentation processes, aligning with the national "dual carbon" strategy [4]. Group 2: Product and Market Focus - The products of Huasai Biotechnology cover areas such as flavor and fragrance, health and nutrition products, raw materials and intermediates, feed additives, and material monomers [5]. - The funds raised will be primarily used for the construction and implementation of green production capacity, which is crucial for transforming laboratory innovations into large-scale market supply [5]. Group 3: Strategic Goals - Huasai Biotechnology expresses gratitude to investors for their recognition and support, emphasizing the strategic synergy brought by the deep layout of capital in emerging industries like biological manufacturing [6]. - The company aims to solidify its technological moat, accelerate capacity construction, and expand market development, aspiring to become a leading force in the industrialization of synthetic biology globally [6].